Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

Cancer Treat Rev. 2004 Oct;30(6):545-54. doi: 10.1016/j.ctrv.2004.04.004.

Abstract

The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for compounds which induce peroxisomal proliferation. PPAR-gamma, the best characterized of the PPARs, is a ligand-activated transcription factor and a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. Recent in vitro and in vivo studies suggest the importance of specific PPAR-gamma ligands as cell-cycle modulators, establishing their antineoplastic properties. In this review, the latest knowledge on the role of PPAR-gamma ligands as cell-cycle modulators is presented, discussing also their role in cell proliferation, apoptosis and cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle Proteins / metabolism*
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism*
  • Receptors, Cytoplasmic and Nuclear / chemistry
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Transcription Factors / chemistry
  • Transcription Factors / metabolism*

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors